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ABSTRACT
Objective: Ministry of Health of Turkey issued a legislation to use only modified electroconvulsive
therapy (ECT) in 2005, and this study aimed to assess satisfaction and attitude of bipolar patients
regarding modified and unmodified electroconvulsive therapy.
Methods: A total of 100 patients (50 treated with modified electroconvulsive therapy (M-ECT) and 50
treated with unmodified ECT (UM-ECT) with a diagnosis of Bipolar Disorder (depressive or manic epi-
sode) were invited to participate in this study. Patients with euthymic mood were included.
Satisfaction and attitude towards ECT were evaluated with a structured attitude questionnaire, and M-
ECT and UM-ECT patients, and their subgroups (depressive vs. manic) were compared.
Results: No significant differences were found between M-ECT and UM-ECT groups regarding age, sex,
marital status and occupation. The majority of all patients (78%) were satisfied from treatment with
ECT and with the outcome (88%), without significant differences between modified and unmodified
groups. Forgetfulness (70%) and headaches (57%) occurred in all groups, with the only significant dif-
ference in forgetfulness being reported by more manic patients treated with UM-ECT. Depressive and
manic patients treated with UM-ECT reported concerns of brain damage and physical harm signifi-
cantly more frequently. While 86% of patients treated with M-ECT consented to a future treatment,
this was significantly less in patients treated with UM-ECT (50%).
Conclusions: Bipolar patients report a high degree of satisfaction treated either with modified or
unmodified ECT but there was a significant difference in perception of adverse effects and willingness
for receiving ECT in future.
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Electroconvulsive therapy (ECT) is one of the oldest biological
treatment modalities and it has been used since 1938 for the
treatment of psychiatric disorders and especially in depression.
This modality is based on the electrical stimulation of the
brain tissues and creation of an epileptic seizure. It was done
unmodified, without muscle relaxants and anaesthesia until
the end of 1940s. Muscle relaxants reduce musculoskeletal
morbidity with electroconvulsive therapy (ECT) but need to be
administered under general anaesthesia [1 (pp: 1–16),2–11].
Recent data of a large retrospective study and two prospect-
ive studies suggest that the risks with unmodified ECT may be
lower than was formerly believed [5,7,12,13]. During the past
three decades or so, the practice of unmodified ECT has been
reported from developing and developed countries, alike.
Electroconvulsive therapy is regarded by almost all psychia-
trists as being a safe and highly effective treatment, consider-
able stigma still surrounds it [14,15]. It still remains one of the
most controversial treatments used in medicine, especially in
the eyes of the lay public [16,17]. Another contributing factor
is the role of the media in shaping attitudes toward treatment
[18]. Conventional research from developed countries has sug-
gested that most patients (50–100%) perceive electroconvul-
sive therapy helpful, most express positive attitudes (60–90%),
and are willing to repeat the treatment (53–98%) if required.
However, a sizeable percentage also has negative views
[11,19]. Attitudes towards unmodified ECT have also been
studied in patients, medical students and psychiatrists. There
are no controlled studies on attitudes towards unmodified
ECT in any population [6,20].
It is seen that mere clinical efficacy of ECT does not
necessarily predict patients’ perceptions or satisfaction. In a
recent depression study by Krech assessing the influence of
pre-treatment expectations, responders and non-responders
did not differ in their rather high expectation of ECT effect-
iveness prior to treatment [21].
Forgetfulness and headache are the most common com-
plaints for ECT treatment. In a review study by Rose et al.
forgetfulness was identified at least in one third (29–79%) of
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the patients after ECT [22,23]. Memory disturbances (11%)
were only reported by patients in the ECT group in a recent
case-control study on remission rates of Transcranial
Magnetic Stimulation (TMS) and ECT [24].
Attitude toward and satisfaction with electroconvulsive
therapy have also been found to be a transcultural issue. In
many developing countries, a paternalistic model of patient
care still predominates, and therefore, any treatment option
recommended by the doctor is generally viewed as an inevit-
able matter of necessity [25]. Electroconvulsive therapy
(mainly unmodified) is used quite frequently in many of the
developing countries [6,26,27]. Electroconvulsive therapy
without anaesthesia was a standard approach in Turkey, until
2005. With the new regulation of the Ministry of Health,
modified electroconvulsive therapy became the standard.
Within a year, which is quite a short time, all psychiatric hos-
pitals switched from unmodified electroconvulsive therapy to
modified ECT [28–31]. Clinical studies in Turkey reported
rates of ECT use in inpatient units ranging between 12.4%
and 16.4%, somewhat higher than Western countries. Few
studies examined knowledge of and attitudes toward ECT
among healthcare professionals, medical students, or lay
people. Aki et al. in a study on attitudes toward and know-
ledge about ECT in Turkish medical students, psychology stu-
dents and a sample of the general public, reported that 3
groups differed in their level of knowledge of ECT, and that
a higher-than-expected proportion of participants in each
group had a positive attitude toward ECT compared with
similar studies. [32]. A study from Turkey examining bipolar
patients who underwent ECT and their relatives reported
that attitudes toward ECT were generally positive among
both patients and their families [33].
In this study we aim to assess the contentment and atti-
tude of patients regarding modified and unmodified ECT. As
healthcare professionals working at a psychiatric facility treat-
ing a large number of psychiatric patients, some with ECT,
we believe that information on attitudes toward ECT can
guide efforts to improve the image [34].
Subjects and methods
This prospective study was conducted between December
2005-March 2007, in Bakirkoy and Erenkoy Teaching
Hospitals, tertiary care neuropsychiatric centers and training
hospitals located in Istanbul, Turkey. Institutional Ethics
Committee approval was obtained before the onset of the
study. All patients were informed about the study and have
signed the informed consent. The study was conducted in
accordance with the Declaration of Helsinki and Good
Clinical Practices.
Participants
Consecutive patients aged 18–65 years, with bipolar manic or
depressive episodes according to DSM IV [35], who were
treated with modified or unmodified electroconvulsive ther-
apy were invited for participation in this study. Patients with
euthymic mood (50 patients treated with modified and 50
patients with unmodified ECT) were included in the study.
They were assessed within the first month (at least 2weeks
after the last treatment) The description of euthymic mood
was having less than 7 points in Hamilton Depression Scale
(HAM-D) and less than 6 points in Young Mania Scale as well
as not having mood symptoms according to DSM- 4 R.
Patients with organic brain disorder, comorbid psychiatric
and medical illness were excluded. The assessments were
carried out by the same investigators (SB and HU).
Sociodemographic and clinical features of the patients who
participated in the study can be seen in Table 1.
ECT procedure
The decision on ECT indication was made by the patients’
attending psychiatrists. A written informed consent is
obtained from the patient if he or she is capable to do so. If
the patient cannot give consent, it is obtained from his or
her legal representative or first degree relatives. The attend-
ing psychiatrist routinely provides information about the pro-
cedure, expected benefits and adverse effects to patients on
the wards before their first ECT session. The consent for
modified ECT also includes consent for general anaesthesia.
In general, patients undergo 7 to 10 ECT sessions, 2 or 3
times a week. Psychiatric, physical, and neurological examina-
tions and laboratory workup are performed in each patient.
An ECT administration form and observation form are filled.
Unmodified ECT was administered in an ECT room (in the
psychiatric ward) with trained nursing staff and electrocon-
vulsive therapy was administered by a resident, under super-
vision of the attending psychiatrist. Patients fasted overnight.
Intramuscular atropine at 0.5mg was given routinely to
reduce the risk of pulmonary aspiration or arrhythmias.
Before the procedure, vital signs were checked by nurses
and electrodes for recording were placed. Electroconvulsive
therapy electrodes were placed in the bilateral fronto-tem-
poral manner, half-age method was used in determining the
initial intensity. The patients were restimulated at a higher
intensity when seizure duration was less than 25 s in EEG
recording. A brief-pulse square-wave ECT device (Thymatron
system IV device; Somatics, Inc., Lake Bluff, IL, USA) was
Table 1. Sociodemographic and clinical features.






(SD ± 12,59) .195

n % n % .167†
Sex Female 25 50% 34 68%
Male 25 50% 16 32%
Marital status Unmarried 13 26% 11 22% .886†
Married 29 58% 30 60%
Widow 8 16% 9 18%
Occupation Has a job 34 68% 25 50% .067†
Jobless 16 32% 25 50%
Diagnosis Bipolar depression 18 36% 11 22% .093†
Bipolar mania 32 64% 39 78%
n: number of patient.Student t test.
†Chi-square test.
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used. Patients were discharged from the ECT room when
their vital signs were stable.
Modified ECT is administered at the ECT Center. After a
preoperative evaluation by an internist and an anaesthesiolo-
gist, the patient is scheduled for the intervention. The
patient is transferred to the ECT Center after a 6-hour fasting
period. In the preparation room, vital signs are checked; the
intravenous line is checked; and electrodes for recording are
placed by nurses. Electroconvulsive therapy is administered
by a resident, under supervision of the attending psychiatrist.
Electroconvulsive therapy electrodes are placed in the bilat-
eral fronto-temporal manner. General anaesthesia is induced
by an anaesthesiologist by intravenous administration of pro-
pofol (0.75–1mg/kg). and succinylcholine (0.5mg/kg). A
brief-pulse square-wave ECT device is used (Thymatron sys-
tem IV device; Somatics, Inc., Lake Bluff, IL, USA). Half-age
method is used in determining the initial intensity. The
patients are re-stimulated at a higher intensity when seizure
duration is less than 25 seconds by EEG recording.
Respiration is maintained using positive pressure ventilation
with 100% oxygen. Patients are discharged from the post-
recovery room when their vital signs are stable.
Sociodemographic and clinical data form
The sociodemographic data form which included data such
as the age, sex, marital status, psychiatric illness and electro-
convulsive treatment history of the patients was filled out by
the investigators.
Satisfaction and attitude questionnaire
This is a self-administered comprehensive and structured
questionnaire in Turkish language and contains 20 items to
assess the patients’ contentment and attitude regarding ECT.
This questionnaire, which was used by Freemen and Kendell
[36] in their study has been translated to Turkish by an
English-speaking psychiatrist and adapted by taking into
consideration the sociocultural factors. For each question the
possible answers are either “true” or “false”. The question-
naire is in three parts: general contentment regarding elec-
troconvulsive therapy, contentment regarding the treatment
results of ECT, and attitude towards adverse effects of ECT.
Statistical analyses
The data was analysed using Statistical Package for the
Social Sciences (SPSS) 20.0. Sociodemographic data for age
examined with Student t test is shown in Table 1. Chi-square
was used for other sociodemographic variables in Table 1.
Chi-square and Fisher’s exact test were used for the compari-
sons of the questionnaire between modified and unmodified
patients in Table 2 and between depressive and manic
patients; and between manic modified-unmodified and
between depressive modified-unmodified patients in .
We compared also ‘headache’ and ‘forgetfulness’ regard-
ing age with Student t test.
Statistical significance was accepted as p< .05.
Results
Sociodemographic and clinical features
No significant differences were found between M-ECT and
UM-ECT groups regarding age, sex and marital status.
Sociodemographic and clinical features of the patients are
presented in Table 1.
Table 2. Attitudes and thoughts regarding ECT.
ECT patients n¼ 100, (%) Modified ECT patients n¼ 50, (%) Unmodified ECT patients n¼ 50, (%)
Overall satisfaction TRUE FALSE TRUE FALSE TRUE FALSE p
ECT is a treatment modality 81 19 37 (%74) 13 (%26) 44 (%88) 6 (%12) .074§
ECT helps people (get well) 78 22 37 (%74) 13 (%26) 41 (%81) 9 (%19) .334§
People shouldn’t be afraid of ECT 65 35 35 15 30 (%60) 20 (%40) .295§
A lot of people have benefited from ECT 70 30 39 (%78) 11 (%22) 31 (%62) 19 (%38) .081§
Contentment about results
I’m content about being treated (with ECT) 78 22 41 (%82) 9 (%18) 37 (%74) 13 (26) .334§
ECT has increased my quality of life 83 17 45 (%90) 5 (%10) 38 12 .062§
I’m content about ECT results 89 11 47 (%94) 3 (%6) 42 8 .200X
ECT increased my functionality 83 17 42 (%84) 8 (%6) 41 9 .790§
ECT is good for my illness 92 8 47 3 45 5 .715X
ECT made me get well rapidly 86 14 47 (%94) 3 (%6) 39 11 .041X <.05
ECT increased my relationship (with other people) 80 20 46 (%92) 4 (%8) 34 (%68) 16 (%32) .005X <.05
Adverse effects
ECTis a painful procedure 34 66 16 (%32) 34 (%68) 18 (%36) 32 (%64) .674§
I remember what I go through ECT 49 51 25 (%50) 25 (%50) 24 (%48) 26 (%52) .841§
ECT causes forgetfulness 70 30 31 (%62) 19 (%38) 39 (%78) 11 (%22) .081§
ECT causes headaches 57 43 29 21 28 (%56) 22 (%44) .840§
Negative Thoughts
ECT causes brain damage 51 49 12 (%24) 38 (%76) 39 (%78) 11 (%22) .000§ <.001
ECTis physically harmful 45 55 12 (%24) 38 (%76) 33 (%66) 17 (%34) .000§ <.001
ECT damages people 44 56 13 (%26) 37 (%74) 31 (%62) 19 (%38) .000§ <.001
ECT disrupts flow of thought 43 57 17 (%34) 33 (%66) 26 (%52) 24 (%48) .069§
Treatment in the future
I agree to be treated with ECT in the future 68 32 43 (%86)þ 7 (%14) 25 (%50) 25 (%50) .000§ <.001
N: indicates number of patients; §: chi-square test; X: fisher’s exact test.
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Satisfaction and attitude
Majority of all patients considered electroconvulsive therapy
beneficial (70%) a treatment modality (81%), which helps
people to get well (78%), improving their quality of life
(84%). There were no differences between M-ECT and UM-
ECT groups, and no differences were found between manic
and depressive patient subgroups. No differences were found
for manic and depressive patients treated with modified
either unmodified ECT.
Majority of patients (M-ECTþUM-ECT) expressed content-
ment with ECT (78%) and with the results (88%). They also
expressed that electroconvulsive therapy was good for their
illness (89%) and helped them get well (84%) rapidly; and
increased their functionality (82%) and sociability (80%). The
only significant difference between unmodified and modified
groups was presence of more patients in the modified group
reporting that ECT helped them get well rapidly and
increased their sociability and reported contentment about
the results. (p< .05).
There were no significant differences between manic and
depressive patient subgroups. No differences were found for
depressive patients treated with modified or unmodified ECT.
More manic patients in modified group were significantly
more positive than unmodified patients for items of quality
of life, sociability, treatment results and speed of recovery.
Two third (65%) of all patients reported no fear from ECT
treatment. There were no differences between UM-ECT and
M-ECT groups. No differences were found between manic
and depressive patients. No differences were found for manic
and depressive patients treated with modified or unmodi-
fied ECT.
Adverse effects – negative thoughts
Forgetfulness was reported by 70% of all patients and there
were no differences between UM-ECT and M-ECT groups. No
differences were found between manic and depressive
patients. Significantly more manic patients treated with
unmodified ECT reported forgetfulness. (p¼ .020). No differ-
ences were found regarding age between patients who did
or did not report forgetfulness and also between patients
treated with modified or unmodified ECT.
Headache was reported by 56% of all patients. There
were no differences for all group comparisons. No differences
were found regarding age between patients who did or did
Table 3. Attitudes and thoughts regarding ECT.
Patients Depressive Patients Manic Patients Depressive patients Manic patients
N¼ 100 N¼ 30 N¼ 70
p
M-ECT ¼ 18 UM-ECT ¼ 12
p
M-ECT ¼ 32 UM-ECT ¼ 38
pOverall satisfaction T F T F T F T F T F T F T F
ECT is a treatment modality 81 19 25 5 56 14 .697§ 14 4 11 1 .622X 23 9 33 5 .119§
ECT helps people (get well) 78 22 24 6 54 16 .752§ 14 4 10 2 1.000X 23 9 31 7 .335§
People shouldn’t be afraid of ECT 65 35 21 9 44 26 .493§ 13 5 8 4 1.000X 22 10 22 16 .349§
A lot of people have
benefited from ECT
70 30 24 6 46 24 .153§ 15 3 9 3 .660X 24 8 22 16 .133§
Contentment about results
I’m content about being
treated with ECT
78 22 26 4 52 18 .199X 15 3 11 1 .632X 26 6 26 12 .221§
ECT has increased my quality of life 83 17 24 6 59 11 .601§ 14 4 10 2 1.000X 31 1 28 10 .009X
p<.05
I’m content about ECT results 89 11 28 2 61 9 .497X 16 2 12 0 .503X 31 1 30 8 .033X
p<.05
ECT increased my functionality 83 17 26 4 57 13 .772X 15 3 11 1 .632X 27 5 30 8 .561§
ECT is good for my illness 92 8 28 2 64 6 1.000X 16 2 12 0 .503X 31 1 33 5 .209X
ECT made me get well rapidly 86 14 26 4 60 10 1.000X 16 2 10 2 1.000X 31 1 29 9 .017X
p<.05
ECT increased my relationship
with others
80 20 24 6 56 14 1.000§ 16 2 8 4 .184X 30 2 26 12 .014X
p<.05
Adverse effects
ECTis a painful procedure 34 66 9 21 25 45 .580§ 3 15 6 6 .102X 13 19 12 26 .431§
I remember what I go through ECT 49 51 11 19 38 32 .106§ 7 11 4 8 1.000X 18 14 20 18 .762§
ECT causes forgetfulness 70 30 19 11 51 19 .341§ 12 6 7 5 .643§ 19 13 32 6 .020
p<.05
ECT causes headaches 57 43 17 13 40 30 .965§ 12 6 5 7 .176§ 17 15 23 15 .533§
Negative Thoughts
ECT causes brain damage 51 49 12 18 39 31 .150§ 4 14 8 4 .024X
p<.05
8 24 31 7 .000§
p<.001
ECTis physically harmful 45 55 10 20 35 35 .125§ 2 16 8 4 .004X
p<.05
10 22 25 13 .004§
p<.05
ECT damages people 44 56 8 22 36 34 .022§
p<.05
1 17 7 5 .003X
p<.05
12 20 24 14 .032§
p<.05
ECT disrupts flow of thought 43 57 11 19 32 38 .402§ 5 13 6 6 .216§ 12 20 20 18 .206§
Treatment in the future
I agree to be treated with
ECT in the future
68 32 23 7 45 25 .224§ 15 3 8 4 .392X 28 4 17 21 .000X
p<.001
N: number of patients; §: chi-square test; X: fisher’s exact test; M-ECT: Modified ECT; UM-ECT: Unmodified ECT.
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not report headache and also between patients treated with
modified or unmodified ECT.
One third of all patients (34%) described electroconvulsive
therapy as a painful procedure and half (49%) reported
remembering it. There was no difference between
any groups.
Negative thoughts Half of all patients (51%) believed in a
possibility of brain damage and fewer of them reported that
ECT was physically harmful and damages people with a sig-
nificant difference (p< .001) between UM and M groups.
More manic patients believe that ECT damages people
(p< .05). Significantly more manic and depressive patients
treated with UM-ECT believe that ECT causes brain damage
(p< .001) and it is physically harmful and damages peo-
ple (p< .05).
Future treatment
If ECT treatment was to be repeated, two thirds of all
patients (68%) consented but M-ECT group was significantly
more willing to accept future ECT treatment in comparison
with the UM-ECT group (p< .001). Manic patients treated
with unmodified ECT were significantly less con-
sented. (p¼ .000)
Attitudes and thoughts regarding electroconvulsive ther-
apy are presented in Tables 2 and 3.
Discussion and conclusion
Bipolar patients report a high degree of satisfaction, irre-
spective of treatment with M or UM-ECT. Our results are
similar to those reported by similar studies, and are in
accordance with the views of Grover who emphasized that
the positive assessment of a treatment is primarily the result
of getting treated [22]. Krech et al. in a recent prospective
study on the influence of depressed patients’ expectations
prior to ECT, report that responders’ rating of ECT effective-
ness remained stable on a high level, non-responders’ rating
decreased significantly [21]. We interviewed the patients
within the first month after the treatment. In studies with a
shorter interval between treatment and interview, with sim-
ple questionnaires, taking place in the hospital where they
were treated, higher satisfaction scores are reported [37].
In the present study one third of the patients expressed
fear from ECT treatment. Although electroconvulsive therapy
is a safe and effective treatment modality, the society and
patients have concerns and anxiety towards ECT [38]. A num-
ber of Western studies have reported that 47% to 75% of
the patients are extremely fearful of electroconvulsive ther-
apy whereas others have concluded that most patients do
not find ECT frightening or upsetting [19]. Early studies of
unmodified electroconvulsive therapy documented high rates
of fear and anxiety, whereas in a historical study Havens
(1959) comparing modified and unmodified electroconvulsive
therapy, did not find a significant difference either in fear
and anxiety before the treatment or afterwards. Gallinek
reported that patients rarely spoke spontaneously about
their fear and required intense direct questioning [39]. James
reported that only 36% of patients perceived the procedure
in some way stressful [40]. It may be a possible expression of
unspoken fear. It is important for clinicians to acknowledge
patients’ concerns and negative feelings toward the treat-
ment, even in the event of a ‘‘good outcome [41].
Similar to previous studies, forgetfulness and headache
were the most common complaints [22]. Rose et al. identi-
fied forgetfulness at least in one third of the patients [23].
Krech et al. found that the patients’ tolerability was not influ-
enced by responder status, and patients with high vs. low
expectations did not report differences in the severity of sub-
jective side effects [21]. Headache was similar in all groups in
our study, but forgetfulness differs significantly between
modified and unmodified manic patients (Unmodified: 84%
and Modified: 60%, (p< .05). Most of studies from Western
countries addressed on unipolar or bipolar or schizoaffective
depressive patient populations [42]. There are few modern
studies on attitudes and satisfaction of manic patients
treated with M-ECT or UM-ECT and thus it is difficult for us
to discuss the significance and importance of these findings.
In an attitude study in bipolar patients treated with bilateral
modified ECT authors reported forgetfulness in 39%,
acknowledging that unfortunately, no data were obtained on
which episode (mania, depression, or mixed) ECT was taken
as an important limitation [33]. James reported forgetfulness
in 30% of all patients (35% bipolar) treated with UM-ECT.
[40]. In the position statement and guidelines on unmodified
ECT, Andrade [6] referring to this study states that headache
and memory impairment may predict negative attitudes
towards ECT. High rates of subjective memory impairment in
our group (70%) may be explained by the relatively short
time interval (within the first month) between treatment and
assessment. Also, preference of bilateral electrode placement
may have played a role. Another influencing factor may be
effects of the drugs which was not included in the design of
the study.
About half of all patients (significantly more in the group
treated with UM-ECT) have concerns of brain damage and
physical harm with ECT treatment. The findings of a very
recent and large study revealed that many members of the
general public who screened positive for depression were
frightened about ECT and had concerns that it was a painful
procedure and could cause brain damage [15].
If ECT treatment was to be repeated, two thirds (68%) of
the patients consented, similar to many other studies
[16,40,42,43,47]. The proportion of patients choosing ECT as
a future treatment option is considered as a measure for the
overall satisfaction with treatment and varies from 36% to
98% [23,36,44]. Sestoft et al. reported that ECT-treated
patients are more likely to prefer ECT in case of future illness,
especially those with a high degree of satisfaction [45].
Unmodified ECT patients were less consented for future ECT
as well as manic patients treated with unmodified ECT.
Gazdag pointed that willingness to consent to ECT is another
sensitive indicator of attitude toward the treatment [46]. As
Sienaert et al. stated patient satisfaction with treatment is
not a clear concept and many other unknown factors may
play a crucial role and the degree of the complaints such as
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memory complaints and headache does not seem to predict
satisfaction with the treatment [41].
Conclusion
Bipolar patients report a high degree of satisfaction treated
either with modified or unmodified ECT but there was a sig-
nificant difference in perception of adverse effects and will-
ingness for receiving ECT in future.
Limitations
Our study groups consisted of patients in remission after
ECT. As we emphasized in our discussion, the positive assess-
ment of a treatment may be primarily the result of getting
treated. Non-responders to ECT might have been less satis-
fied with the treatment they had [37]. We think that it is
important to share the results of this study carried out in the
transition period, since unmodified electroconvulsive therapy
is no longer used as a treatment modality. However, it is the
main restriction of this study, since it cannot be repeated
under same circumstances.
Geolocation information
Bakirkoy Teaching Hospital for Psychiatry, Neurology and
Neurosurgery and Erenkoy Teaching Hospital for Psychiatry
and Neurology are tertiary care neuropsychiatry centers and
training hospitals located in Istanbul, Turkey.
The catchment area has a population of approximately
16 million.
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